SPAN-PD: Subgroup Analyses by Baseline Characteristics of Patients Treated With Levodopa Inhalation Powder 84mg or Placebo to Treat OFF Symptoms in Patients With Parkinson's Disease (PD) as Measured by Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) Score and Patient Global Impression of Change (PGIC)
Levodopa
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: SPAN-PD: Subgroup Analyses by Baseline Characteristics of Patients Treated With Levodopa Inhalation Powder 84mg or Placebo to Treat OFF Symptoms in Patients With Parkinson's Disease (PD) as Measured by Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) Score and Patient Global Impression of Change (PGIC) ### Output: Levodopa